Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Commitments and Contingencies (Tables)

Note 6 - Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Restructuring and Related Costs [Table Text Block]

		Continuing				Discontinued
		Operations				Operations				Total

Balance as of December 31, 2015		$	2,011			$	1,074			$	3,085
Accruals			459				659				1,118
Payments			(140	)			(388	)			(528	)
Balance as of March 31, 2016		$	2,330			$	1,345			$	3,675